Bingyi Lin

1.3k total citations · 2 hit papers
48 papers, 910 citations indexed

About

Bingyi Lin is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Bingyi Lin has authored 48 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Bingyi Lin's work include Organ Transplantation Techniques and Outcomes (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Bingyi Lin is often cited by papers focused on Organ Transplantation Techniques and Outcomes (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Bingyi Lin collaborates with scholars based in China, United States and Macao. Bingyi Lin's co-authors include Shusen Zheng, Lei Geng, Liming Wu, Wen Yi, Ling Tang, Shuming Hu, Lin Zhou, Rong Cai, Qiang Zhu and Haiyang Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Bingyi Lin

46 papers receiving 900 citations

Hit Papers

NRF2, a Superstar of Ferroptosis 2023 2026 2024 2025 2023 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NRF2, a Superstar of Ferroptosis
    2023 127 citations Bingyi Lin, Ling Tang et al. Antioxidants profile →
  2. O -GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation
    2023 85 citations Bingyi Lin, Wen Yi et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingyi Lin China 18 455 190 183 169 130 48 910
Wenjie Zheng China 18 621 1.4× 227 1.2× 355 1.9× 160 0.9× 148 1.1× 65 1.1k
Moo Jun Baek South Korea 20 532 1.2× 492 2.6× 245 1.3× 196 1.2× 174 1.3× 87 1.3k
Xueliang Zhou China 16 372 0.8× 258 1.4× 190 1.0× 259 1.5× 99 0.8× 82 901
Guoan Xiang China 17 439 1.0× 192 1.0× 210 1.1× 111 0.7× 140 1.1× 50 853
Yajin Chen China 15 550 1.2× 235 1.2× 340 1.9× 165 1.0× 149 1.1× 43 959
Chloé Sauzay France 12 329 0.7× 150 0.8× 204 1.1× 160 0.9× 58 0.4× 19 671
Yongfu Xiong China 19 516 1.1× 254 1.3× 312 1.7× 211 1.2× 102 0.8× 56 1.0k
Fengkai Sun China 16 311 0.7× 213 1.1× 176 1.0× 99 0.6× 107 0.8× 42 734
Jing Fu China 17 359 0.8× 168 0.9× 185 1.0× 59 0.3× 63 0.5× 42 768

Countries citing papers authored by Bingyi Lin

Since Specialization
Citations

This map shows the geographic impact of Bingyi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyi Lin more than expected).

Fields of papers citing papers by Bingyi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingyi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyi Lin. The network helps show where Bingyi Lin may publish in the future.

Co-authorship network of co-authors of Bingyi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Bingyi Lin. A scholar is included among the top collaborators of Bingyi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingyi Lin. Bingyi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Liyang, Shushu Song, Yong Wang, et al.. (2025). Mina53 catalyzes arginine demethylation of p53 to promote tumor growth. Cell Reports. 44(2). 115242–115242. 1 indexed citations
2.
Liu, Tao, Zhijian Chen, Bingyi Lin, et al.. (2025). Exposure to low concentrations of PM2.5 and its constituents with preterm birth in Shenzhen, China: a retrospective cohort study. BMC Public Health. 25(1). 1295–1295. 1 indexed citations
3.
Liu, Tao, Bingyi Lin, Jing Yi, et al.. (2024). Association of PM2.5 exposure in early pregnancy and maternal liver function: A retrospective cohort study in Shenzhen, China. Environmental Research. 263(Pt 1). 119934–119934. 2 indexed citations
4.
Li, Jingchao, Bingyi Lin, Liming Wu, et al.. (2024). O-GlcNAcylation of enolase 1 serves as a dual regulator of aerobic glycolysis and immune evasion in colorectal cancer. Proceedings of the National Academy of Sciences. 121(44). e2408354121–e2408354121. 9 indexed citations
5.
Li, Xiaotian, Wei Lin, Lingfang Zeng, et al.. (2024). Microplastic Particles Detected in Fetal Cord Blood, Placenta, and Meconium: A Pilot Study of Nine Mother–Infant Pairs in South China. Toxics. 12(12). 850–850. 12 indexed citations
6.
Lin, Bingyi, et al.. (2023). NRF2, a Superstar of Ferroptosis. Antioxidants. 12(9). 1739–1739. 127 indexed citations breakdown →
7.
Pang, Yoong Xin, Chenyang Lu, Bingyi Lin, et al.. (2021). The Impact of COVID-19 on the Global Graphene Industry. 6(3). 1–3. 3 indexed citations
8.
Shen, Tian, Lei Geng, Zhengtao Liu, et al.. (2020). Experience With Anti-PD-1 Antibody, Camrelizumab, Monotherapy for Biliary Tract Cancer Patients and Literature Review. Technology in Cancer Research & Treatment. 19. 1079247351–1079247351. 6 indexed citations
9.
Wu, Liming, Hui He, Gang Chen, et al.. (2020). Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese. Hepatobiliary & pancreatic diseases international. 19(3). 252–257. 4 indexed citations
10.
Wu, Liming, Bingyi Lin, Yang Huang, et al.. (2019). Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy. Acta Biomaterialia. 86. 363–372. 56 indexed citations
11.
Zhang, Aibin, Zhihao Zhang, Jie Zhang, et al.. (2019). Lower mean platelet volume is a risk indicator of hepatocellular carcinoma recurrence following liver transplantation. Hepatobiliary & pancreatic diseases international. 18(3). 223–227. 9 indexed citations
12.
Geng, Lei, Lidong Wang, Tian Shen, et al.. (2018). Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes. Hepatobiliary & pancreatic diseases international. 17(3). 204–209. 10 indexed citations
13.
Geng, Lei, Jingfeng Liu, Bingyi Lin, et al.. (2018). A high frequency of CD8+CD28- T-suppressor cells contributes to maintaining stable graft function and reducing immunosuppressant dosage after liver transplantation. International Journal of Medical Sciences. 15(9). 892–899. 5 indexed citations
14.
15.
Lin, Bingyi, Lin Zhou, Lei Geng, et al.. (2015). High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation. World Journal of Gastroenterology. 21(11). 3317–3324. 25 indexed citations
16.
17.
Lin, Bingyi, et al.. (2015). The evaluation of enteric-coated mycophenolate sodium in cardiac deceased donor liver transplant patients in China. Immunopharmacology and Immunotoxicology. 37(6). 508–512. 1 indexed citations
18.
Gao, Sheng, Zhe Yang, Haiyang Xie, et al.. (2014). Single Nucleotide Polymorphisms in the Metastasis-associated in Colon Cancer-1 Gene Predict the Recurrence of Hepatocellular Carcinoma after Transplantation. International Journal of Medical Sciences. 11(2). 142–150. 20 indexed citations
19.
Teng, Lisong, Xingyun Su, Xin Xu, et al.. (2014). ER-α36: a novel biomarker and potential therapeutic target in breast cancer. OncoTargets and Therapy. 7. 1525–1525. 32 indexed citations
20.
Li, Huiqi, Lu Yao, Tao Ouyang, et al.. (2006). Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival. Carcinogenesis. 28(2). 372–377. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjie Zheng Breakdown of academic impact, for papers by Moo Jun Baek Breakdown of academic impact, for papers by Xueliang Zhou Breakdown of academic impact, for papers by Guoan Xiang Breakdown of academic impact, for papers by Yajin Chen Breakdown of academic impact, for papers by Chloé Sauzay Breakdown of academic impact, for papers by Yongfu Xiong Breakdown of academic impact, for papers by Fengkai Sun Breakdown of academic impact, for papers by Jing Fu
Rankless by CCL
2026